[Federal Register Volume 65, Number 27 (Wednesday, February 9, 2000)]
[Notices]
[Page 6386]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 00-2908]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel, Memorial Sloan Kettering Cancer Gene Therapy Program.
    Date: February 8-10, 2000.
    Time: 7 p.m. to 12 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Fitzpatrick Manhattan Hotel, 687 Lexington Avenue, New 
York, NY 10022.
    Contact Person: Mary Bell, PhD, Scientific Review Administrator, 
Grants Review Branch, National Cancer Institute, National Institutes 
of Health, 6130 Executive Boulevard, Rockville, MD 20892, 301/496-
7978.
    This notice is being published less than 15 days prior to the 
meeting due to the timing limitations imposed by the review and 
funding cycle.

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction; 93.393, Cancer Cause and Prevention Research; 
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer 
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer 
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer 
Control, National Institutes of Health, HHS)

    Dated: February 3, 2000.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 00-2908 Filed 2-8-00; 8:45 am]
BILLING CODE 4140-01-M